Lemborexant
Back to searchMolecule Structure
Scientific Name
Lemborexant
Description of the Drug
Lemborexant is a dual orexin antagonist indicated for the treatment of sleep-onset and/or sleep maintenance insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11951
http://www.drugbank.ca/drugs/DB11951
Brand Name(s)
Dayvigo
Company Owner(s)
Eisai Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Orexin receptor 1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL5113 |
Orexin receptor 2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL4792 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2116558 | |
DrugBank | DB11951 | |
PubChem: Thomson Pharma | 135646445 | |
PubChem | 56944144 | |
Nikkaji | J3.610.985H | |
PDBe | NRK | |
BindingDB | 50093793 | |
DrugCentral | 5360 | |
ChemicalBook | CB72744022 | |
Guide to Pharmacology | 9302 | |
rxnorm | DAYVIGO | LEMBOREXANT |
ZINC | ZINC000118073503 |